MRCP2-4635
An 80-year-old woman presents to the rheumatology outpatient clinic with a history of Giant Cell Arteritis diagnosed 3 years ago. Despite being on prednisolone 8 mg, she has been unable to taper down the dose due to excruciating temporal headaches, weakness, and fatigue. Previous attempts to lower the dose have resulted in mild visual loss, requiring hospitalization. She is also on zoledronic acid for osteoporosis, with recent vertebral fractures. Concerned about the side effects of steroids, including diabetes and weight gain, she asks about alternative treatment options for her condition. What are the available management options for this patient’s Giant Cell Arteritis?